Take the new global CI Benchmarking survey (and see your results instantly!)

Posted by Fuld + Company on Aug 5, 2015 9:12:47 AM

How does your CI program compare to other across the globe?

Competitive intelligence (CI) is just over three decades old and plays a critical role in corporate decision making around the world. Join over 700 companies that have participated in this Fuld + Company survey over the past 10 years. By participating in the 2015 benchmark update, you will learn the latest information on CI budgets, reporting relationships, as well as understanding how strategic or how tactical your CI program is compared to others in your industry or in other geographies.

Read More

Topics: Competitive Intelligence, Consumer Goods, War Games, Brand Insights, Fuld + Company, Market Analysis, Pharma, Scenario Analysis, Technology/Telecomm, Life Sciences, Merger and Acquisition

Healthcare Merger Mania Continues

Posted by Ken Sawka on Jul 29, 2015 11:55:01 AM

Anthem last week agreed to acquire Cigna for $48.3 billion, according to multiple press reports. The deal, if approved, would create the nation’s largest insurer in terms of enrollment, and reduce the number of large health insurers from five to three. Coming on the heels of the announced tie-up of Aetna and Humana – a $37 billion dollar transaction itself – the deal is almost certain to raise antitrust concerns.

AetnaHumanaMerger

The Risks and Drama of Merger Mania - Can We Learn from Experience?
By: Diane Borska

Read More

Topics: Competitive Intelligence, Events, Brand Insights, Market Analysis, Pharma, Healthcare, Industry Convergence, Life Sciences, Merger and Acquisition

Upcoming Event: Fuld at World CDx Boston 2015

Posted by Fuld + Company on Jul 13, 2015 2:07:54 PM

Join us this year at World CDx Boston 2015 taking place September 8-11 at the Hilton Hotel in Boston's Logan Airport. Members of our life sciences team will be at our booth to engage with you, and help you learn what Fuld + Company can do for all your competitive intelligence needs! Be sure to stop by our booth.

Read More

Topics: Competitive Intelligence, Events, Fuld + Company, Innovation, Healthcare, Industry Convergence, Life Sciences

Upcoming Event: Fuld at Pharma CI USA 2015

Posted by Fuld + Company on Jul 13, 2015 2:06:17 PM

Join us this year at Pharma CI USA 2015 taking place September 10-11 at the Hilton Parsippany Hotel in New Jersey. Members of our life sciences team will be at our booth to engage with you, and help you learn what Fuld + Company can do for all your competitive intelligence needs! Be sure to stop by our booth.

Read More

Topics: Competitive Intelligence, Events, Fuld + Company, Innovation, Scenario Analysis, Healthcare, Industry Convergence, Life Sciences

The Risks and Drama of Merger Mania - Can We Learn from Experience?

Posted by Diane Borska on Jul 13, 2015 10:00:00 AM

UPDATE: Robust analytical methodologies can provide executives with insight regarding industry trends. This blog, previously produced by Diane Borska, Global Principal at Fuld + Company, on mergers and acquisitions is a demonstration of the power of strong industry understanding and well-executed analysis

Nearly 18 months after the Aetna – Humana deal was first announced, a federal judge has ruled the transaction would violate antitrust laws. As a result, it is all but certain that the deal will not go forward and analysts believe the closure of the other significant industry transaction involving Anthem and Cigna, is also in jeopardy. Observing the parallels of merger activity in another industry with relevant characteristics to health insurers, allowed us to recognize early on the risks these transactions would face and conclude that the pace of industry consolidation may be slow and face considerable challenges.

Read More

Topics: Competitive Intelligence, Events, Brand Insights, Market Analysis, Pharma, Healthcare, Industry Convergence, Life Sciences, Merger and Acquisition

Fuld + Company Names David Staknis, Ph. D., Senior Vice President for Global Life Sciences Practice

Posted by Fuld + Company on Jul 8, 2015 3:39:00 PM

BOSTON, MA, July 8 2015 — Fuld + Company announced that David Staknis is its new senior vice president and head of the global life sciences practice. David has been with Fuld for more than seven years in both a project manager and director role, and brings a combination of deep life sciences industry experience, strong knowledge of all aspects of Fuld + Company’s services and value, and excellent client relationship management experience.

Read More

Topics: Events, Fuld + Company, Life Sciences

Aetna's Medicare Advantage Bet

Posted by Jacob Golbitz on Jul 8, 2015 3:38:00 PM

Last week Aetna announced its intention to acquire Humana for $37 billion in cash and stock. Reasons given for the acquisition included the usual references to synergy potential, cost savings, and greater financial strength, but also how the acquisition will improve membership positioning and increase government exposure in its covered lives portfolio.

Read More

Topics: Competitive Intelligence, Events, Brand Insights, Market Analysis, Pharma, Healthcare, Industry Convergence, Life Sciences, Merger and Acquisition

Knowing when to reject advice and why

Posted by Leonard Fuld on Jul 1, 2015 9:40:00 AM

An interview and discussion with Michel Darnaud, former President of Boston Scientific

During 2003-2004, the President of Boston Scientific Europe, Michel Darnaud, faced a critical decision: How to successfully roll out a new clot-resistant stent in the European marketplace against a gargantuan competitor with a product already in place. That competitor was Johnson & Johnson.

Read More

Topics: Competitive Intelligence, Consumer Goods, Product Roadmap, Brand Insights, Innovation, Market Analysis, Healthcare, Life Sciences, Product Positioning

Social Media: A Competitive Analysis Resource for Chronic Disease

Posted by Leonard Fuld on Jun 26, 2015 12:00:00 PM

Chronic disease is a frustrating, emotionally exhausting, and sometimes life-threatening experience. That’s what makes it such a data-rich opportunity for analyzing how a rival might be tapping into this market.

Back in 2001, before Facebook, Twitter, LinkedIn and online heath forums, the World Wide Web was a wild frontier of informal discussion groups and list serves. Daniel Vasella, former CEO of Novartis, once wrote: “There is real power in the Internet as a source of information, but especially as a way to connect with each other, to share experiences, knowledge and help each other.” (Magic Cancer Bullet, Daniel Vasella and Robert Slater, Copyright 2003, page 126)

Read More

Topics: Competitive Intelligence, Innovation, Scenario Analysis, Healthcare, Industry Convergence, Life Sciences

Healthcare Delivery is Becoming More Decentralized: An Opportunity for Insurers?

Posted by Jacob Golbitz on Jun 23, 2015 2:00:00 PM

As part of CVS’s acquisition of Target’s 1,660 pharmacies, CVS announced it will rebrand Target’s nearly 80 in-store clinics as MinuteClinic and open up 20 new clinics within Target stores over the next 3 years – all this as part of the company’s plan to operate 1,500 clinics by 2017.

Earlier in June CVS announced it had become an in-network provider with Molina Healthcare of Ohio, a health care insurance plan operating in Ohio with 340,000 members. This makes sense for Molina, as the MinuteClinics lower cost will lower Molina’s costs, and members benefit as well with increased convenience and accessibility.

Read More

Topics: Consumer Goods, Brand Insights, Market Analysis, Pharma, Healthcare, Life Sciences, Merger and Acquisition

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.